Hypocretin-1/orexin-A fragment1-16 as a potential surrogate marker for diagnosing narcolepsy type 1. [PDF]
Wenz ES +18 more
europepmc +1 more source
Sleep-related eating disorder after dose escalation of sodium oxybate in narcolepsy type 1. [PDF]
Al Mazyad RA +3 more
europepmc +1 more source
Postmortem Evidence of CRH Neuron Reduction in Narcolepsy Without Cataplexy With Borderline Hypocretin-1 Levels. [PDF]
Shan L +5 more
europepmc +1 more source
Narcolepsy: immunity, neural circuitry, and brain network reconfiguration. [PDF]
Chen J, Wang Y, Bai Y, Cai Y.
europepmc +1 more source
Novel Compounds as Orexin 2 Receptor Agonists for Treating Narcolepsy. [PDF]
Sabnis RW, Sabnis AR.
europepmc +1 more source
Wilson's Disease Coexisting with Narcolepsy Type 1: Evidence for a Multifactorial Cause of Excessive Daytime Sleepiness from a Case Report. [PDF]
Xu Z, Wang Y, Xu C, Hou Z, Yang W.
europepmc +1 more source
Polysomnographic and Clinical Characteristics of Narcolepsy in Saudi Arabia: <i>A 12-Year Retrospective Study</i>. [PDF]
Almalki B +6 more
europepmc +1 more source
Current and Emerging Therapies for Pediatric Sleep Disorders: A Narrative Review. [PDF]
Estrada Chaverri L +2 more
europepmc +1 more source
Cerebrospinal fluid orexin testing in Australians with narcolepsy type 1. [PDF]
Fernando M +8 more
europepmc +1 more source

